Sanofi’s stock outlook has weakened as TD Cowen lowered its sales forecast for tolebrutinib




Sanofi’s stock outlook has weakened as TD Cowen lowered its sales forecast for tolebrutinib



Source link

  • Related Posts

    Neuralink plans ‘high-volume’ brain implant production by 2026, Musk said

    Neuralink plans ‘high-volume’ brain implant production by 2026, Musk said Source link

    CTRA: What does Argus say about CTRA?

    CTRA: What does Argus say about CTRA? Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *